• If you are wondering whether Synopsys stock is priced attractively or already baking in high expectations, this valuation breakdown is designed to give you a clear and structured view.
• Recently, the share price closed at US$461.50, with a 2.9% gain over the past week, but a decline of 12.1% over the last month and 3.9% so far this year, including a 3.6% decline over the past 12 months.
• These mixed returns have kept Synopsys in focus as investors weigh long term prospects against current pricing. Evergreen interest in the stock, along with ongoing product and industry coverage, provides useful context for why the share price has been recalibrating rather than moving in a straight line.
• On Simply Wall St’s valuation framework, Synopsys currently scores 2 out of 6 on its value checks. This sets up a closer look at how different methods such as DCFs, multiples, and peer comparisons line up, and why a more narrative based view of valuation later in the article may matter just as much as the numbers themselves.

Synopsys scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Synopsys Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes projections of future cash flows and discounts them back to today using a required return. The aim is to estimate what Synopsys stock might be worth based on cash it could generate for shareholders.

For Synopsys, the model uses a 2 Stage Free Cash Flow to Equity approach, starting from last twelve month free cash flow of about $2.6b. Analysts provide explicit forecasts for several years, and Simply Wall St then extends these cash flows further out, including a projected free cash flow of $4.9b in 2030. Each of these future figures is discounted back to today to reflect timing and risk.

Combining these discounted projections results in an estimated intrinsic value of $464.11 per share. Compared with the recent share price of $461.50, the model suggests Synopsys is about 0.6% undervalued, which is effectively a tight range around the current market price.

Result: ABOUT RIGHT

Synopsys is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Approach 2: Synopsys Price vs Earnings

For profitable companies like Synopsys, the P/E ratio is a widely used way to think about valuation because it links what you pay for the stock directly to the earnings it generates. A higher or lower P/E often reflects what the market is pricing in for future growth and the level of risk investors are willing to accept.

In general, stronger expected earnings growth and lower perceived risk can support a higher “normal” or “fair” P/E ratio, while slower growth or higher uncertainty tend to justify a lower one. Synopsys currently trades on a P/E of 114.28x, compared with an average of 32.80x for peers and 25.49x for the broader Software industry.

Simply Wall St’s Fair Ratio for Synopsys is 52.08x. This is a proprietary estimate of what the P/E might be, given factors such as earnings growth, profit margins, industry, market cap and risk profile. Because it incorporates these company specific drivers, the Fair Ratio can be more informative than a simple comparison with peer or industry averages. Set against the current P/E of 114.28x, the Fair Ratio points to Synopsys stock trading above that model based level.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Synopsys Narrative

Earlier it was mentioned that there is an even better way to understand valuation. This is where Narratives come in for Synopsys, giving you a clear story behind the numbers such as fair value, and assumptions about future revenue, earnings and margins.

A Narrative is simply your view of what the company is doing, why it matters, and how that might translate into financial forecasts that link directly to a fair value estimate.

On Simply Wall St, Narratives sit in the Community page and are used by millions of investors as an easy, accessible tool that connects a company’s story to a forecast model. They then compare that Fair Value to the current market price to help decide whether the stock looks attractive or extended.

Because Narratives update when new information such as news or earnings is added to the platform, different investors can see their Synopsys views evolve in real time. For example, one investor may justify a higher fair value based on their expectations, while another uses more cautious assumptions that point to a lower fair value.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.